Abstract
Bronchoalveolar lavage (BAL) is a procedure that can be used to collect samples from human and animal lungs to efficiently evaluate the immune response and the potentially pathological changes by examining both the compositions of cells and fluid from lavage. There are observable changes including inflammatory response in human and animal lungs exposed to environmental exposures such as toxic chemicals and microorganisms, or under pathophysiological conditions in respiratory system. The profile of inflammatory cells in BAL provides a qualitative description of inflammatory response, and the secretion in BAL fluid contains secreted proteins of inflammatory mediators and albumin as a quantitative measurement of inflammation and tissue injury in the lungs. Mouse is the most common model system being used for pulmonary disease-related research. A consistent experimental approach on how to lavage mouse lungs and collect samples from mouse lungs is important for a reproducible evaluation of pathological and physiological changes in mouse lung especially for the analysis of inflammation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Henderson AJ (1994) Bronchoalveolar lavage. Arch Dis Child 70:167–169
Rose AS, Knox KS (2007) Bronchoalveolar lavage as a research tool. Semin Respir Crit Care Med 28:561–573
Martin WR, Padrid PA, Cross CE (1990) Bronchoalveolar lavage. Clin Rev Allergy 8:305–332
Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B, American Thoracic Society Committee on, B. A. L. i. I. L. D (2012) An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185:1004–1014
Baughman RP (2007) Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 28:475–485
Tinkle SS, Schwitters PW, Newman LS (1996) Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Environ Health Perspect 104(Suppl 5):969–971
Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, Kellokumpu-Lehtinen P (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy—association of interleukin-8 and VEGF with survival. Cytokine 50:30–36
Van Hoecke L, Job ER, Saelens X, Roose K (2017) Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J Vis Exp. https://doi.org/10.3791/55398
Irvin C, Zafar I, Good J, Rollins D, Christianson C, Gorska MM, Martin RJ, Alam R (2014) Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol 134(1175–1186):e1177
Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, Bel EH, Bossuyt PM (2015) Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med 3:290–300
Barczyk A, Pierzchala W, Caramori G, Wiaderkiewicz R, Kaminski M, Barnes PJ, Adcock IM (2014) Decreased percentage of CD4(+)Foxp3(+)TGF-beta(+) and increased percentage of CD4(+)IL-17(+) cells in bronchoalveolar lavage of asthmatics. J Inflamm 11:22
Guerra S, Vasquez MM, Spangenberg A, Halonen M, Martin RJ (2016) Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthma. J Allergy Clin Immunol 138(932–934):e931
Affolter K, Tamm M, Jahn K, Halter J, Passweg J, Hirsch HH, Stolz D (2014) Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease. Am J Respir Crit Care Med 190:309–317
Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, Rijnders BJ (2015) Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol 53:868–874
Mutschlechner W, Risslegger B, Willinger B, Hoenigl M, Bucher B, Eschertzhuber S, Lass-Florl C (2015) Bronchoalveolar lavage fluid (1,3)beta-D-Glucan for the diagnosis of invasive fungal infections in solid organ transplantation: a prospective multicenter study. Transplantation 99:e140–e144
Babu PB, Chidekel A, Shaffer TH (2004) Association of interleukin-8 with inflammatory and innate immune components in bronchoalveolar lavage of children with chronic respiratory diseases. Clin Chim Acta 350:195–200
Hodge G, Hodge S, Reynolds PN, Holmes M (2008) Airway infection in stable lung transplant patients is associated with decreased intracellular T-helper type 1 pro-inflammatory cytokines in bronchoalveolar lavage T-cell subsets. Transpl Infect Dis 10:99–105
Kahn FW, Jones JM (1987) Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 155:862–869
Campbell AJ, Noble DW (2007) Bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Anaesthesia 62:1078
Nakos G, Tsangaris H, Liokatis S, Kitsiouli E, Lekka ME (2003) Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis. Intensive Care Med 29:555–563
Samanta S, Poddar B, Azim A, Singh RK, Gurjar M, Baronia AK (2018) Significance of mini bronchoalveolar lavage fluid amylase level in ventilator-associated pneumonia: a prospective observational study. Crit Care Med 46:71–78
Royer S, Prescott HC (2018) Next steps for confirming bronchoalveolar lavage amlyase as an useful biomarker for ventilator-associated pneumonia. Crit Care Med 46:165–166
Kalanuria AA, Ziai W, Mirski M (2014) Ventilator-associated pneumonia in the ICU. Crit Care 18:208
van Maarsseveen TC, Stam J, Calame JJ (1990) T lymphocytosis in a bronchoalveolar lavage of a pulmonary adenocarcinoma: case report. Respiration 57:57–61
de Gracia J, Bravo C, Miravitlles M, Tallada N, Orriols R, Bellmunt J, Vendrell M, Morell F (1993) Diagnostic value of bronchoalveolar lavage in peripheral lung cancer. Am Rev Respir Dis 147:649–652
Domagala-Kulawik J, Guzman J, Costabel U (2003) Immune cells in bronchoalveolar lavage in peripheral lung cancer--analysis of 140 cases. Respiration 70:43–48
Oshita F, Nomura I, Yamada K, Kato Y, Tanaka G, Noda K (1999) Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions. Clin Cancer Res 5:617–620
Semenzato G, Spatafora M, Feruglio C, Pace E, Dipietro V (1990) Bronchoalveolar lavage and the immunology of lung cancer. Lung 168(Suppl):1041–1049
Chellapandian D, Lehrnbecher T, Phillips B, Fisher BT, Zaoutis TE, Steinbach WJ, Beyene J, Sung L (2015) Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol 33:501–509
Chen Z, Xu Z, Sun S, Yu Y, Lv D, Cao C, Deng Z (2014) TGF-beta1, IL-6, and TNF-alpha in bronchoalveolar lavage fluid: useful markers for lung cancer? Sci Rep 4:5595
Verleden SE, Ruttens D, Vandermeulen E, van Raemdonck DE, Vanaudenaerde BM, Verleden GM, Vos R (2014) Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation. Transplantation 97:83–89
Speck NE, Schuurmans MM, Benden C, Robinson CA, Huber LC (2017) Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers. Respir Res 18:151
Husain S, Resende MR, Rajwans N, Zamel R, Pilewski JM, Crespo MM, Singer LG, McCurry KR, Kolls JK, Keshavjee S, Liles WC (2014) Elevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation. Transplantation 97:90–97
Low RB (1989) Bronchoalveolar lavage lipids in idiopathic pulmonary fibrosis. Chest 95:3–5
Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047
Pesci A, Ricchiuti E, Ruggiero R, De Micheli A (2010) Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us? Respir Med 104(Suppl 1):S70–S73
Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A (2009) Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78:285–292
Weinberger SE, Kelman JA, Elson NA, Young RC Jr, Reynolds HY, Fulmer JD, Crystal RG (1978) Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 89:459–466
Daubeuf F, Frossard N (2012) Performing bronchoalveolar lavage in the mouse. Curr Protoc Mouse Biol 2:167–175
Abe K, Kadota J, Ishimatsu Y, Iwashita T, Tomono K, Kawakami K, Kohno S (2000) Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences. Microbiol Immunol 44:849–855
Kayes SG, Jones RE, Omholt PE (1987) Use of bronchoalveolar lavage to compare local pulmonary immunity with the systemic immune response of Toxocara canis-infected mice. Infect Immun 55:2132–2136
Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, Leikauf GD, Kolls JK, Di YP (2011) Antimicrobial activity of PLUNC protects against pseudomonas aeruginosa Infection. J Immunol 187:382–390
Jahnz-Rozyk KM, Kuna P, Pirozynska E (1997) Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. J Investig Allergol Clin Immunol 7:254–259
Zhang L, Wang M, Kang X, Boontheung P, Li N, Nel AE, Loo JA (2009) Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res 8:1631–1638
Hasegawa S, Wakiguchi H, Okada S, Gui Kang Y, Fujii N, Hasegawa M, Hasegawa H, Ainai A, Atsuta R, Shirabe K, Toda S, Wakabayashi-Takahara M, Morishima T, Ichiyama T (2014) Cytokine profile of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during seasonal H1N1 infection. Cytokine 69:206–210
Chang CC, Chen SH, Ho SH, Yang CY, Wang HD, Tsai ML (2007) Proteomic analysis of proteins from bronchoalveolar lavage fluid reveals the action mechanism of ultrafine carbon black-induced lung injury in mice. Proteomics 7:4388–4397
Duniho SM, Martin J, Forster JS, Cascio MB, Moran TS, Carpin LB, Sciuto AM (2002) Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene. Toxicol Pathol 30:339–349
Henderson RF, Benson JM, Hahn FF, Hobbs CH, Jones RK, Mauderly JL, McClellan RO, Pickrell JA (1985) New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysis. Fundam Appl Toxicol 5:451–458
Vergadi E, Vaporidi K, Theodorakis EE, Doxaki C, Lagoudaki E, Ieronymaki E, Alexaki VI, Helms M, Kondili E, Soennichsen B, Stathopoulos EN, Margioris AN, Georgopoulos D, Tsatsanis C (2014) Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J Immunol 192:394–406
Micale RT, D'Agostini F, Steele VE, La Maestra S, De Flora S (2008) Budesonide and phenethyl isothiocyanate attenuate DNA damage in bronchoalveolar lavage cells of mice exposed to environmental cigarette smoke. Curr Cancer Drug Targets 8:703–708
Pounds JG, Flora JW, Adkins JN, Lee KM, Rana GS, Sengupta T, Smith RD, McKinney WJ (2008) Characterization of the mouse bronchoalveolar lavage proteome by micro-capillary LC-FTICR mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 864:95–101
Conickx G, Avila Cobos F, van den Berge M, Faiz A, Timens W, Hiemstra PS, Joos GF, Brusselle GG, Mestdagh P, Bracke KR (2017) microRNA profiling in lung tissue and bronchoalveolar lavage of cigarette smoke-exposed mice and in COPD patients: a translational approach. Sci Rep 7:12871
Guoping C, Fan P, Jingxi S, Xiaoping L, Shiqin J, Yuri L (1997) Purification and characterization of a silica-induced bronchoalveolar lavage protein with fibroblast growth-promoting activity. J Cell Biochem 67:257–264
Maeda A, Ishioka S, Taooka Y, Hiyama K, Yamakido M (1999) Expression of transforming growth factor-beta1 and tumour necrosis factor-alpha in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin. Respirology 4:359–363
Kitagawa M, Kuwashima Y, Nemoto T, Seki S, Matsubara O, Kasuga T (1990) In vivo dynamics of pulmonary lymphoid cell subpopulations generated against pulmonary metastasis: evaluation by bronchoalveolar lavage fluid. Virchows Arch B Cell Pathol Incl Mol Pathol 58:365–370
Janick-Buckner D, Ranges GE, Hacker MP (1989) Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice. Toxicol Appl Pharmacol 100:465–473
Harada C, Kawaguchi T, Ogata-Suetsugu S, Yamada M, Hamada N, Maeyama T, Souzaki R, Tajiri T, Taguchi T, Kuwano K, Nakanishi Y (2011) EGFR tyrosine kinase inhibition worsens acute lung injury in mice with repairing airway epithelium. Am J Respir Crit Care Med 183:743–751
Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Garza NT, Vo TT, Newman RA, Aggarwal BB, Evans CM, Tuvim MJ, Lotan R, Dickey BF (2009) Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 30:1949–1956
Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB (2011) Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384
Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM, Lung HIV M. P (2013) Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187:1067–1075
Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, Li Y, Shen N, Ghedin E, Morris A, Diaz P, Huang L, Wikoff WR, Ubeda C, Artacho A, Rom WN, Sterman DH, Collman RG, Blaser MJ, Weiden MD (2016) Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol 1:16031
Mould KJ, Jackson ND, Henson PM, Seibold M, Janssen WJ (2019) Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets. JCI Insight 4:126556
Fischer N, Indenbirken D, Meyer T, Lutgehetmann M, Lellek H, Spohn M, Aepfelbacher M, Alawi M, Grundhoff A (2015) Evaluation of unbiased next-generation sequencing of RNA (RNA-seq) as a diagnostic method in influenza virus-positive respiratory samples. J Clin Microbiol 53:2238–2250
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Di, M.E., Yang, D., Di, Y.P. (2020). Using Bronchoalveolar Lavage to Evaluate Changes in Pulmonary Diseases. In: Keohavong, P., Singh, K., Gao, W. (eds) Molecular Toxicology Protocols. Methods in Molecular Biology, vol 2102. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0223-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0223-2_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0222-5
Online ISBN: 978-1-0716-0223-2
eBook Packages: Springer Protocols